Inhibition of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase by the selected plant extracts

Abstract

W there are more than 370 million people who are chronically infected with Hepatitis B Virus (HBV) and at the risk of developing liver cirrhosis and hepatocellular carcinoma. More than one million people die every year due to complications of HBV-related chronic liver disease. Antiviral agents can efficiently control virus replication, but rarely eliminate the virus and the emergence of mutant strains of the virus is a major disadvantage. Host immune help is needed in the complete elimination of viral infection. Immunotherapeutic approaches to treating chronic HBV infection is a major unmet medical need, and currently none is available.